Literature DB >> 28623030

Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.

James Zengel1, Shannon I Phan1, Adrian Pickar2, Pei Xu3, Biao He4.   

Abstract

Mumps virus (MuV) causes acute infection in humans with characteristic swelling of the parotid gland. While vaccination has greatly reduced the incidence of MuV infection, there have been multiple large outbreaks of mumps virus (MuV) in highly vaccinated populations. The most common vaccine strain, Jeryl Lynn, belongs to genotype A, which is no longer a circulating genotype. We have developed two vaccine candidates that match the circulating genotypes in the United States (genotype G) and China (genotype F). We found that there was a significant decrease in the ability of the Jeryl Lynn vaccine to produce neutralizing antibody responses to non-matched viruses, when compared to either of our vaccine candidates. Our data suggests that an updated vaccine may allow for better immunity against the circulating MuV genotypes G and F.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genotype F; Genotype G; Mumps; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28623030      PMCID: PMC5785236          DOI: 10.1016/j.vaccine.2017.05.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

1.  Mumps meningitis and orchitis without parotitis.

Authors:  R S DEWAR
Journal:  Lancet       Date:  1950-02-11       Impact factor: 79.321

2.  Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus.

Authors:  Pei Xu; Zhuo Li; Dengyun Sun; Yuan Lin; Jianguo Wu; Paul A Rota; Biao He
Journal:  Virology       Date:  2011-06-14       Impact factor: 3.616

3.  Identification of conformational neutralization sites on the fusion protein of mumps virus.

Authors:  Maja Šantak; Claes Örvell; Tanja Košutić Gulija
Journal:  J Gen Virol       Date:  2015-01-22       Impact factor: 3.891

4.  Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012).

Authors:  Sigrid Gouma; Jussi Sane; Daphne Gijselaar; Jeroen Cremer; Susan Hahné; Marion Koopmans; Rob van Binnendijk
Journal:  J Gen Virol       Date:  2014-03-06       Impact factor: 3.891

5.  Waning immunity against mumps in vaccinated young adults, France 2013.

Authors:  Sabine Vygen; Aurélie Fischer; Laure Meurice; Ibrahim Mounchetrou Njoya; Marina Gregoris; Bakhao Ndiaye; Adrien Ghenassia; Isabelle Poujol; Jean Paul Stahl; Denise Antona; Yann Le Strat; Daniel Levy-Bruhl; Patrick Rolland
Journal:  Euro Surveill       Date:  2016

6.  New evidence of the influence of exogenous and endogenous factors on sperm count in man.

Authors:  Wai Yee Wong; Gerhard A Zielhuis; Chris M G Thomas; Hans M W M Merkus; Régine P M Steegers-Theunissen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-09-10       Impact factor: 2.435

7.  Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein.

Authors:  Gerardo Santos-López; Thomas Scior; María del Tránsito Borraz-Argüello; Verónica Vallejo-Ruiz; Irma Herrera-Camacho; José Tapia-Ramírez; Julio Reyes-Leyva
Journal:  Braz J Infect Dis       Date:  2009-02       Impact factor: 1.949

8.  Recent resurgence of mumps in the United States.

Authors:  Gustavo H Dayan; M Patricia Quinlisk; Amy A Parker; Albert E Barskey; Meghan L Harris; Jennifer M Hill Schwartz; Kae Hunt; Carol G Finley; Dennis P Leschinsky; Anne L O'Keefe; Joshua Clayton; Lon K Kightlinger; Eden G Dietle; Jeffrey Berg; Cynthia L Kenyon; Susan T Goldstein; Shannon K Stokley; Susan B Redd; Paul A Rota; Jennifer Rota; Daoling Bi; Sandra W Roush; Carolyn B Bridges; Tammy A Santibanez; Umesh Parashar; William J Bellini; Jane F Seward
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

9.  Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines.

Authors:  Heikki Peltola; Prasad S Kulkarni; Subhash V Kapre; Mikko Paunio; Suresh S Jadhav; Rajeev M Dhere
Journal:  Clin Infect Dis       Date:  2007-07-10       Impact factor: 9.079

Review 10.  Resurgence of mumps in Korea.

Authors:  Sun Hee Park
Journal:  Infect Chemother       Date:  2015-03-30
View more
  5 in total

Review 1.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.

Authors:  Kelsey Briggs; Cara Kirby; Ashley C Beavis; James Zengel; Preetish Patil; Christian Sauder; Biao He
Journal:  J Virol       Date:  2022-04-07       Impact factor: 6.549

3.  Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.

Authors:  Sigrid Gouma; Tessa Vermeire; Steven Van Gucht; Lennart Martens; Veronik Hutse; Jeroen Cremer; Paul A Rota; Geert Leroux-Roels; Marion Koopmans; Rob van Binnendijk; Elien Vandermarliere
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

4.  Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Authors:  Tetsuo Nakayama; Masahiro Eda; Motonori Hirano; Wakako Goto
Journal:  Hum Vaccin Immunother       Date:  2019-04-22       Impact factor: 3.452

Review 5.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.